MedhaviGuptaMD

Physician

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Blackstone Street
3RD floor
Providence, RI 02903
Phone+1 401-453-7520

Fax+1 401-453-7529

Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2015 - 2018
Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2015 - 2018
B. J. Medical College AhmedabadClass of 2013

PubMed

8 citations
Exploring the role of survivin in neuroendocrine neoplasms.
Ahmad Hanif, Sunyoung S. Lee, Medhavi Gupta, Ankush Chander, Eric Kannisto
Oncotarget. 2020-06-09
9 citations
Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review.
Rohit Gosain, Medhavi Gupta, Arya Mariam Roy, Jonathan Strosberg, Kathryn M Glaser
Cancers. 2022-03-10
21 citations
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
Medhavi Gupta, Christopher Sherrow, Maghan E. Krone, Edik M. Blais, Michael J. Pishvaian
Journal of the National Comprehensive Cancer Network. 2021-01-06

Lectures

A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO).
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Phase II study of nanoliposomal irinotecan (nal-IRI) with 5-fluorouracil (5-FU)/folinic acid (FA) in refractory advanced high-grade neuroendocrine cancer (HG-NEC) of g...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020